<DOC>
	<DOCNO>NCT00005676</DOCNO>
	<brief_summary>To investigate relative contribution high density lipoprotein-C ( HDL-C ) subspecies risk coronary heart disease ( CHD ) two distinct exist population ( sample VA-HIT study Framingham Offspring Study [ FOS ] ) well response subfractions gemfibrozil treatment .</brief_summary>
	<brief_title>High Density Lipoprotein Subspecies Coronary Disease</brief_title>
	<detailed_description>BACKGROUND : Coronary heart disease ( CHD ) continue lead cause death disability United States . Information contribution different subspecies HDL-C increase decrease risk premature CHD extent common lipoprotein lipase ( LPL ) mutation affect HDL-C composition subspecies could contribute increase understanding role HDL-C determine CHD risk . DESIGN NARRATIVE : The follow parameter measure blood sample collect VA-HIT study Framingham Offspring Study : apo A-I-containing HDL subspecies ( prebeta , alpha , prealpha ) plasma use two-dimensional gel electrophoresis immunoblot image analysis , LpA-I LpA-I/A-II plasma use differential electroimmunoassay , apo C-III HDL use immunoturbidometric assay . The study hypotheses follow . ) Subjects placebo arm VA-HIT significantly low alpha l HDL subspecies , LpA-I , apo C-III HDL , high HDL/alpha l apo A-I/alpha l ratio subject free coronary heart disease Framingham Offspring Study . b ) These parameter also predict prospectively risk coronary heart disease group . c ) In VA-HIT study , treatment gemfibrozil , show associate 22 percent reduction myocardial infarction coronary heart disease death , associate increase alpha l HDL subspecies , LpA-I , apo C-III HDL , well decrease HDL/alpha l apo A-I/alpha l ratio , compare placebo . ) The hypothesis subject specific mutation lipoprotein lipase gene less beneficial change HDL subspecies gemfibrozil subject mutation also test .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Arteriosclerosis</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<criteria>VAHIT : men , establish CHD , HDLC &lt; 40 mg/dl , LDLC &lt; 140 mg/dl , TG &lt; 300 mg/dl FOS : men evidence CHD</criteria>
	<gender>Male</gender>
	<minimum_age>41 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>